Condition
Bariatric Patients
Total Trials
5
Recruiting
1
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Completed3
Recruiting1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07401394Not ApplicableActive Not Recruiting
BAR-TAX - Tranexamic Acid in Bariatric Surgery.
NCT06987903Not ApplicableRecruiting
Impact of a Perioperative Physical Exercise and Respiratory Physiotherapy Program on the Patient Undergoing Bariatric Surgery
NCT00497627CompletedPrimary
Quality of Life and Cardiometabolic Risk Factors in Patients After Debanding
NCT02713113Phase 3CompletedPrimary
Efficacy of Low Dose Sugammadex in Reversal of NMB in Laparoscopic Barbaric Surgery
NCT01248312CompletedPrimary
Incidence of Hypercapnea in Morbidly Obese Post-Surgical Bariatric Patients Using the Sen Tec Transcutaneous PCO2 Monitor
Showing all 5 trials